Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Dihydrotestosterone (DHT) promotes the growth and spread of aggressive brain tumor cells.

Four new cases of Bachmann-Bupp syndrome suggest potential for targeted treatment.

TCDD reduces EGF receptors in the liver, affecting growth and development.

5-Bromo-3,4-dihydroxybenzaldehyde could potentially help hair growth by activating certain cell pathways and inhibiting others.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

Systemic photodynamic therapy can effectively treat stubborn folliculitis decalvans with few side effects.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Pentoxifylline effectively improves pretibial pruritic papular dermatitis.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Photobiomodulation therapy can reduce pain and inflammation and help heal tissues, but more research is needed to improve its effectiveness and safety.

Photobiomodulation therapy effectively promotes hair regrowth and improves quality of life in alopecia areata without side effects.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

PDRN helps repair tissue and improve wound healing with a high safety profile.